Related Experiment Video

Updated: Dec 9, 2025

A Technique for Subcutaneous Abdominal Adipose Tissue Biopsy via a Non-diathermy Method
09:01

A Technique for Subcutaneous Abdominal Adipose Tissue Biopsy via a Non-diathermy Method

Published on: September 30, 2017

15.7K

Looking for a needle in a haystack: an older diabetic man with cheiroarthropathy loses an insulin pen needle in

Iacopo Iacomelli1, Chiara Giulietti2, Mauro Di Bari3

  • 1Diabetes Clinic and Geriatric Clinic, Department of Internal and Specialist Medicine, Internal Medicine Unit, Santa Maria alla Gruccia - Valdarno Hospital, Azienda USL Toscana Sud Est, Piazza del Volontariato 2, 52025, Montevarchi, Arezzo, Italy. iac_iacopo@hotmail.com.

Aging Clinical and Experimental Research
|September 5, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
DetachmentDiabetic cheiroarthropathyElderlyInsulin penNeedle

More Related Videos

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster05:52

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster

Published on: June 30, 2011

20.2K
A Simplified Technique for Producing an Ischemic Wound Model12:00

A Simplified Technique for Producing an Ischemic Wound Model

Published on: May 2, 2012

17.6K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
531
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
530